Dianthus Therapeutics (DNTH) Leases (2022 - 2025)
Dianthus Therapeutics (DNTH) has 4 years of Leases data on record, last reported at $1.3 million in Q3 2025.
- For Q3 2025, Leases rose 271.02% year-over-year to $1.3 million; the TTM value through Sep 2025 reached $1.3 million, up 271.02%, while the annual FY2024 figure was $1.6 million, 152.52% up from the prior year.
- Leases reached $1.3 million in Q3 2025 per DNTH's latest filing, down from $1.4 million in the prior quarter.
- Across five years, Leases topped out at $25.4 million in Q1 2022 and bottomed at $352000.0 in Q3 2024.
- Average Leases over 4 years is $6.4 million, with a median of $1.3 million recorded in 2025.
- Peak YoY movement for Leases: plummeted 97.08% in 2023, then soared 271.02% in 2025.
- A 4-year view of Leases shows it stood at $814000.0 in 2022, then decreased by 24.45% to $615000.0 in 2023, then surged by 152.52% to $1.6 million in 2024, then decreased by 15.9% to $1.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $1.3 million in Q3 2025, $1.4 million in Q2 2025, and $1.4 million in Q1 2025.